Moderna Inc (Moderna) operates as a developer of messenger RNA therapeutics. The company develops and discovers drugs that produce proteins or antibodies inside patient cells. Its pipeline includes various drug modalities such as prophylactic vaccines, therapeutic vaccines, intratumoral immuno-oncology, localized therapeutics, and liver intracellular. Moderna through its mRNA therapeutics platform develops and produces human proteins, antibodies, and novel proteins, which help in preventing, treating, and curing diseases. It also develops therapeutics in the areas of infectious disease, rare liver disease, immuno-oncology, and cardiovascular disease. Moderna Therapeutics is headquartered in Cambridge, Massachusetts, the US.

Headquarters United States of America

Address 200 Technology Sq, Cambridge, Massachusetts, 02139-3578


Telephone 1 617 7146500

No of Employees 2,700

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange MRNA (NASD)

Revenue (2021) $18.5B 2199.1% (2021 vs 2020)

EPS XXX

Net Income (2021) XXX 1733.3% (2021 vs 2020)

Market Cap* $67.6B

Net Profit Margin (2021) XXX 171.0% (2021 vs 2020)

* As of and is in US$

Access premium data and analytics for Moderna Inc

220+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Moderna Inc’s relevant decision makers and contact details.

140+

Catalyst Calendar

Proactively evaluate Moderna Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

80+

Pipeline Drugs

Identify which of Moderna Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

80+

Clinical Trials

Determine Moderna Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

40+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

17+

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

3

Marketed Drugs

Understand Moderna Inc’s commercialized product portfolio to stay one step ahead of the market.

230+

Install Base

Install Base provides a holistic and a granular view of the IT product/service deployments from leading vendors. Explore IT infrastructure categories, solution and product/service areas deployed by a prospect.

1

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

1

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for Moderna Inc (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Moderna Inc’s likely spend across technology areas enabling you to understand the digital strategy.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products Brands
Pipeline Spikevax
mRNA-1273 : COVID-19 vaccine
mRNA-1273.351 : COVID-19 vaccine Beta variant
XXX
XXX
XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2022 Contracts/Agreements In October, the company extended its partnership with Merck to jointly develop and sell mRNA-4157/V940, an investigational personalised cancer vaccine (PCV).
2022 Contracts/Agreements In October, the company entered into an agreement with Gavi for the delivery of Covid-19 vaccines to lower-income countries.
2022 Regulatory Approval In October, the company received emergency use authorization from Taiwan for second-generation COVID-19 vaccines.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Moderna Inc Johnson & Johnson AstraZeneca Plc Coherus BioSciences Inc Adimab LLC
Headquarters United States of America United States of America United Kingdom United States of America United States of America
City Cambridge New Brunswick Cambridge Redwood City Lebanon
State/Province Massachusetts New Jersey Cambridgeshire California New Hampshire
No. of Employees 2,700 141,700 83,100 368 -
Entity Type Public Public Public Public Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Noubar Afeyan, PhD Chairman Executive Board 2012 59
Stephane Bancel Chief Executive Officer; Director Executive Board 2011 49
James Mock Chief Financial Officer Senior Management 2022 -
Shannon Thyme Klinger Chief Legal Officer; Secretary Senior Management 2021 50
Kate Cronin Chief Brand Officer Senior Management 2021 56
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company Analytics

Contact the team or request a demo to find out how our data can drive your business forward

Why are you leaving?